Roxadustat (FibroGen/Astellas/AstraZeneca) Drug Analysis 2018 - ResearchAndMarkets.com

DUBLIN--()--The "Drug Analysis: Roxadustat" drug pipelines has been added to ResearchAndMarkets.com's offering.

Roxadustat (FibroGen/Astellas/AstraZeneca) is a hypoxia-inducible factor (HIF) prolyl-hydroxylase inhibitor in development for the treatment of anemia in chronic kidney disease. The drug is administered orally three times per week and mimics the body's natural response to reduced oxygen levels by increasing levels of HIFs. These factors are involved in erythropoiesis. Roxadustat treats anemia primarily by reducing hepcidin levels, increasing iron transport and absorption proteins, and stimulating erythropoietin production.

Key Topics Covered:

List of Figures

Figure 1: Roxadustat for anemia in chronic kidney disease - SWOT analysis

Figure 2: Drug assessment summary of roxadustat for anemia in chronic kidney disease

Figure 3: Drug assessment summary of roxadustat for anemia in chronic kidney disease

Figure 4: Roxadustat sales for anemia in chronic kidney disease across the US, Japan, and five major EU markets, by country, 2015-24

List of Tables

Table 1: Roxadustat drug profile

Table 2: Roxadustat Phase III trials in anemia in chronic kidney disease

Table 3: Roxadustat Phase II and III data in anemia in chronic kidney disease

Table 4: Roxadustat sales for anemia in chronic kidney disease across the US, Japan, and five major EU markets, by country ($m), 2015-24

For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/t3xcgb/roxadustat?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Hematological Drugs

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Hematological Drugs